Literature DB >> 6478339

A case-control study of alcohol consumption and drinking behaviour in patients with acute gout.

C R Sharpe.   

Abstract

The alcohol intake and drinking behaviour of 24 patients who presented with acute gout in a family practice over a 5-year period were compared with these features of a control population matched for sex, age, weight and use of hyperuricemia-inducing diuretics. The average weekly alcohol intake of the group with gout was twice that of the control group (p less than 0.02), and a statistically significant relation was found between alcohol abuse and acute gout (p less than 0.05). About half of the patients with gout drank excessively. Acute gout should be considered a possible clinical sign of alcohol abuse.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478339      PMCID: PMC1483603     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  17 in total

1.  Psychobiological variables in the onset and recurrence of gouty arthritis: a chronic disease model.

Authors:  J L Katz; H Weiner
Journal:  J Chronic Dis       Date:  1975-01

Review 2.  Epidemiology of alcoholic liver disease.

Authors:  W K Lelbach
Journal:  Prog Liver Dis       Date:  1976

3.  Hyperuricemia and gout in an employee population.

Authors:  J J Thorpe; J M Daley
Journal:  J Occup Med       Date:  1971-11

4.  The prevalence of chronic disease among problem drinkers.

Authors:  S Pell; C A D'Alonzo
Journal:  Arch Environ Health       Date:  1968-05

5.  Relation of serum uric acid to body bulk, haemoglobin, and alcohol intake in two South Pacific Polynesian populations.

Authors:  J G Evans; I A Prior; H P Harvey
Journal:  Ann Rheum Dis       Date:  1968-07       Impact factor: 19.103

6.  Hyperuricemia induced by alcohol.

Authors:  C S Lieber
Journal:  Arthritis Rheum       Date:  1965-10

7.  Alcohol consumption and gout.

Authors:  B M Saker; O B Tofler; M J Burvill; K A Reilly
Journal:  Med J Aust       Date:  1967-06-17       Impact factor: 7.738

8.  The relation of adiposity to blood pressure and development of hypertension. The Framingham study.

Authors:  W B Kannel; N Brand; J J Skinner; T R Dawber; P M McNamara
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

9.  ALCOHOLISM IN TUBERCULOUS PATIENTS.

Authors:  T A PINCOCK
Journal:  Can Med Assoc J       Date:  1964-10-17       Impact factor: 8.262

10.  Alcohol consumption and blood pressure. Kaiser-Permanente Multiphasic Health Examination data.

Authors:  A L Klatsky; G D Friedman; A B Siegelaub; M J Gérard
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

View more
  7 in total

1.  Serum uric acid is associated with dietary and lifestyle factors in elderly women in suburban Guangzhou in Guangdong province of south China.

Authors:  Z Xiong; C Zhu; X Qian; J Zhu; Z Wu; L Chen
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

2.  Liver disease in the alcoholic.

Authors:  A Szilagyi
Journal:  Can Fam Physician       Date:  1986-09       Impact factor: 3.275

Review 3.  Management of acute and chronic gouty arthritis: present state-of-the-art.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Vitamin C intake and the risk of gout in men: a prospective study.

Authors:  Hyon K Choi; Xiang Gao; Gary Curhan
Journal:  Arch Intern Med       Date:  2009-03-09

5.  Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men.

Authors:  Paul T Williams
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045

6.  Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.

Authors:  Hyon K Choi; Gary Curhan
Journal:  BMJ       Date:  2008-01-31

Review 7.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.